Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')₂ fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study (Q41495598)
Jump to navigation
Jump to search
scientific article published on 5 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')₂ fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study |
scientific article published on 5 February 2015 |
Statements
1 reference
Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')₂ fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study (English)
1 reference
Paul A Tambyah
1 reference
Céline Bal
1 reference
Cécile H Herbreteau
1 reference
Sareth Rith
1 reference
Masliza Zaid
1 reference
William Kristanto
1 reference
Velda Han
1 reference
Charlotte Reynaud
1 reference
Patrick Granjard
1 reference
Bertrand Lépine
1 reference
Caroline Durand
1 reference
5 February 2015
1 reference
1 reference
15
1 reference
3
1 reference
285-292
1 reference
Identifiers
1 reference
1 reference